relative to breast cancer mortality within an influential clinical trial. I conclude with some responses to the evolving …

and cervical cancer among uninsured women in the US: one that paid for cancer screenings with federal funds and one that … paid for cancer treatments under state Medicaid programs. Using variation in rollout of each program across states from … 1991-2005, we find that funding for cancer treatment did not significantly increase most types of cancer screenings for …

recommendation. We explore this distinction in the context of recommendations that breast cancer screening start at age 40. The raw … data suggest that responders to the age 40 recommendation have less cancer than do women who self-select into screening at … recommendation also have less cancer than women who never screen, suggesting that the benefits of recommending early screening are …

cancer. We used a regression discontinuity design to assess impacts of near-universal Medicare insurance at age 65 on cancer … detection and outcomes, using population-based cancer registries and vital statistics data. Our analysis focused on the three … tumor sites for which screening is recommended both before and after age 65: breast, colorectal, and lung cancer. At age 65 …

I investigate whether the types of cancer (breast, colon, lung, etc.) subject to greater penetration of new ideas had … cancer sites combined may have been due to the increase in the novelty of medical ideas 12-24 years earlier …The number of years of potential life lost from cancer before ages 80 and 70 are inversely related to the novelty of …

, we focus on patients newly diagnosed with cancer. They display the familiar pattern: even among cancer patients with … reductions. We also find that among patients with the same cancer type and initial prognosis, end-of-life spending is …

of these effects vary sharply. Cardiovascular disease, cancer, and HIV are the most significant sources of mortality rate …

not consistent with current recommendations of the American Cancer Society …

Previous investigators argued that increasing 5-year survival for cancer patients should not be taken as evidence of …We reexamine the question of whether increasing 5-year survival rates constitute evidence of success against cancer …While the change in the 5-year survival rate is not a perfect measure of progress against cancer, in part because it is …